1. Home
  2. FND vs PCVX Comparison

FND vs PCVX Comparison

Compare FND & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Floor & Decor Holdings Inc.

FND

Floor & Decor Holdings Inc.

HOLD

Current Price

$53.22

Market Cap

5.3B

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$62.79

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FND
PCVX
Founded
2000
2013
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
8.7B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
FND
PCVX
Price
$53.22
$62.79
Analyst Decision
Buy
Strong Buy
Analyst Count
16
5
Target Price
$77.25
$88.25
AVG Volume (30 Days)
2.9M
1.2M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
1.05
N/A
EPS
1.92
N/A
Revenue
$4,684,088,000.00
N/A
Revenue This Year
$7.56
N/A
Revenue Next Year
$7.78
N/A
P/E Ratio
$26.09
N/A
Revenue Growth
5.12
N/A
52 Week Low
$46.47
$28.09
52 Week High
$92.41
$65.00

Technical Indicators

Market Signals
Indicator
FND
PCVX
Relative Strength Index (RSI) 48.33 65.54
Support Level $46.47 $42.30
Resistance Level $64.23 $65.00
Average True Range (ATR) 2.57 2.28
MACD 0.81 0.62
Stochastic Oscillator 87.19 95.44

Price Performance

Historical Comparison
FND
PCVX

About FND Floor & Decor Holdings Inc.

Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site. The company segments include retail segment and others.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: